Lynda Charters

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Researchers are looking for options to reduce corneal surface flora in patients

The COVID-19 global pandemic continues to have an impact on ophthalmologists, their practices and daily life. For patients, there can be additional pressures that are concerning.

ASRS 2020 coverage: Peter Campochiaro, MD, detailed findings of phase 2 of the Ladder Trial and ongoing Archway Trial during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

ASRS 2020 coverage: The results of the Protocol T Extension Study underscore the need for methods to improve long-term visual gains in eyes with diabetic macular edema, according to Dante Pieramici, MD,on behalf of the DRCR Retina Network.

Trabeculectomy may offer better results with more severe glaucoma

ASRS 2020 coverage: Carl Danzig, MD, presented results of phase 2 Stairway Trial during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting. Faricimab is a bispecific antibody that simultaneously inhibits angiopoietin-2 and vascular endothelial growth factor A.

Technology is off to a good start, but improvements still needed

New research is looking past just regulating the IOP, using a single-cell RNA to identify 12 distinct cell types in trabecular meshwork.

ASRS 2020 coverage: An augmented-reality device provides AMD patients with enhanced reading ability and facial recognition.

ASRS 2020 coverage: Intravitreal liposome-encapsulated bromfenac is under study as a treatment for refractory DME. Results of a pilot study were detailed at the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

ASRS 2020 coverage: The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.

Diagnostic and monitoring advances in glaucoma need fine-tuning

Columbia University researchers have successfully isolated antibodies from severely ill, ventilated patients who recovered from COVID-19.

With an eye on innovation, money is driving research of new therapies and devices.

Industry develops creative approaches to help increase patient medication adherence

According to an interim analysis, the phase 1 trial of the messenger RNA (mRNA)-1273 vaccine conducted by Moderna is showing promising results.

One company is providing urgent eye care to patients in a refugee camp settlement of Rohingya.

Panel discusses IOP monitoring, drug delivery, data collection

For many physicians, “moral injury” may be actual issue

A new study from China found that about half of the patients hospitalized with COVID-19 are hyperglycemic.

Future entry into country for graduate medical students, research fellows at risk

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

A new recommendation by six medical societies touts adherence to meeting the daily recommended dose of vitamin D.

Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma

There are other mimickers of NTG that should be kept in mind

Physicians must play a critical role in setting the tone in an ophthalmology facility

New products increase the chance of early diagnosis

Amid the COVID-19 pandemic, a smart thermometer has become a valuable tool in detecting coronavirus hotspots.

While the spikes that are characteristic of COVID-19 are well-documented, researchers have detected a subtle change from the onset of the pandemic in January to May, when the virus ultimately engulfed New York City.